Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-30248

ABSTRACT: Expression analysis of eu-miR-155 transgenic mice B-cells.

OTHER RELATED OMICS DATASETS IN: PRJNA143781

PROVIDER: E-GEOD-30248 | ExpressionAtlas | 2014-10-10

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-30248-analysis-methods.tsv	Tabular
	E-GEOD-30248-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-30248-configuration.xml	Xml
	E-GEOD-30248-percentile-ranks.tsv	Tabular
	E-GEOD-30248.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 61

Similar Datasets

Mus musculus

Project description:Expression analysis of eu-miR-155 transgenic mice B-cells.

| PRJNA143781 | ENA

Mechanisms associated with systemic effects of cancer

Project description:Cancer is considered as a disease of a specific organ, but its effects are felt throughout the body. The systemic effects of cancer can lead to weakness in muscles and heart, which hastens cancer-associated death. miR-486 is a myogenic microRNA and its reduced expression in skeletal muscle is observed in muscular dystrophy. Muscle-specific transgenic expression of miR-486 using muscle creatine kinase promoter (MCK-miR-486) partially rescues skeletal muscle defects in muscular dystrophy animal models. We had previously demonstrated reduced circulating and skeletal muscle levels of miR-486 in several cancer types and lower miR-486 levels correlated with skeletal muscle defects and functional limitations in mammary tumor models. Therefore, skeletal muscle defects induced by cancer could resemble defects observed in various dystrophies, which could be reversed through skeletal muscle expression of miR-486. We performed functional limitations studies and biochemical analysis of skeletal muscles of MMTV-Neu transgenic mice that mimic HER2+ breast cancer and MMTV-PyMT transgenic mice that mimic luminal subtype B breast cancer and these mice crossed to MCK-miR-486 transgenic mice. miR-486 significantly prevented tumor-induced reduction in muscle contraction force, grip strength, and rotarod performance in MMTV-Neu, but not in MMTV-PyMT mice. In MMTV-Neu model, miR-486 reversed several of the cancer-induced changes in skeletal muscle including loss of p53, phospho-AKT, and phospho-laminin alpha 2 (LAMA2) and gain of phosphorylation of the pre-mRNA processing factor hnRNPA0 and the splicing factor SRSF10. LAMA2 is a part of the dystrophin-associated glycoprotein complex, and its loss-of-function mutation is associated with congenital muscular dystrophy. Thus, similar to muscular dystrophy, miR-486 has the potential to reverse skeletal muscle defects and cancer burden in select cancer types.

2022-05-19 | PXD028554 | Pride

Mus musculus

Project description:Expression analysis of miR-499 transgenic heart

| PRJNA126685 | ENA

Mus musculus

Project description:GFAP transgenic mice expression analysis

| PRJNA88019 | ENA

The microRNA-200 family regulates pancreatic beta-cell survival in type 2 diabetes (islet)

Project description:Islets from control and beta-cell specific miR-141/200c overexpressing mice were extracted and Affymetrix gene expression analysis performed We used Affymetrix Chip analysis to address which genes are regulated upon miR-200-overexpression in beta-cells at the age of 6 weeks. Transgenic mice overexpressing miR-141/200c and control mice were subjected to islet extraction, RNA was extracted using Trizol method, and Affymetrix analysis was performed.

2015-05-06 | E-GEOD-58488 | biostudies-arrayexpress

Mus musculus

Project description:Expression of miR-196a in Huntington's disease transgenic (HD) mice

| PRJNA205896 | ENA

Expression of miR-196a in Huntington's disease transgenic (HD) mice

2013-05-30 | GSE47500 | GEO

Mus musculus

Project description:Follicular B (FoB) cells purified from miR-17-92 transgenic mice

| PRJNA144263 | ENA

Expression of miR-196a in Huntington's disease transgenic (HD) mice

Project description:We intend to screen altered genes after overexpression of miR-196a in HD transgenic mice. Two transgenic mouse lines were used in this study, including HD transgenic mice and HD transgenic mice overexpressing miR-196a. The mice were all at approximate 12 months of age. At this point, HD transgenic mice showed severve motor dysfunctions, whereas HD transgenic mice overexpressing miR-196a displayed mild motor dysfunctions. We used the striatum tissues from 2 HD transgenic mice and 3 HD transgenic mice overexpressing miR-196a. The mice were all at approximate 12 months of age. Two technique repeats were performed for each sample.

2013-05-30 | E-GEOD-47500 | biostudies-arrayexpress

Effect of transgenic miR-32 expression on hiMYC-driven prostate cancer in vivo

Project description:We compare the overall gene expression of transgenic mice expressing the MYC oncogene (hiMYC mice) to induce tumorigenesis in the mouse prostate with mice having transgenic expression of the microRNA miR-32 in hiMYC background to determine whether increased expression of miR-32 influences growth or phenotype in prostate adenocarcinoma in vivo.

2021-03-23 | GSE169323 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data